Tiziana Life Sciences Ltd: To Dose First Patient With Moderate Alzheimer's Disease With Foralumab
tiziana life sciences將首次對中度阿爾茨海默病患者使用法魯單抗進行劑量注射
Tiziana Life Sciences Ltd: To Dose First Patient With Moderate Alzheimer's Disease With Foralumab
tiziana life sciences將首次對中度阿爾茨海默病患者使用法魯單抗進行劑量注射
譯文內容由第三人軟體翻譯。